Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04704193|
Recruitment Status : Recruiting
First Posted : January 11, 2021
Last Update Posted : January 11, 2021
|Condition or disease||Intervention/treatment||Phase|
|Genetic Testing||Other: Survey of Decision Aid||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes|
|Actual Study Start Date :||November 20, 2020|
|Estimated Primary Completion Date :||December 31, 2022|
|Estimated Study Completion Date :||December 31, 2022|
Experimental: Electronic Decision Aid
Participants in this arm will complete an electronic decision aid for genetic testing.
Other: Survey of Decision Aid
The decision aid will be evaluated by a survey administered to those who have used the tool.
- Participant satisfaction with how educational information is presented in the decision aid [ Time Frame: This outcome will be measured immediately following completion of the decision aid ]Measured with 6 items on a questionnaire that asks participants to rate the way certain information is presented on the decision aid. Each item is rated on a scale of 1 to 4, with 1 being poor and 4 being excellent.
- Total time spent on decision aid [ Time Frame: From the start of the decision aid to the completion of the decision aid ]The total amount of minutes spent on the decision aid
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04704193
|Contact: Daniel C Chung, MDfirstname.lastname@example.org|
|Contact: Ava Siegelemail@example.com|
|United States, Massachusetts|
|Massachusetts General Hospital||Recruiting|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator: Daniel Chung, MD|
|Principal Investigator:||Daniel C Chung, MD||Massachusetts General Hospital|